Sentara TPN Products Recalled Due to Lack of Sterility Assurance
Sentara Infusion Services is recalling 26 bags of Total Parenteral Nutrition (TPN) solutions distributed nationwide because the manufacturer cannot assure the products maintain sterility. Patients receiving these products should contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or confirmed contamination. This qualifies as a risk-of-harm product where injury has not yet been reported, meeting the High severity criterion. Parenteral nutrition products lacking sterility assurance present a theoretical but serious risk of bloodstream infection.
Plain-English summary
Sentara Infusion Services is recalling 26 bags of Total Parenteral Nutrition (TPN) solutions in multiple formulations dispensed to patients nationwide.
The recall was issued because the manufacturer cannot assure sterility of the products. Total Parenteral Nutrition is administered intravenously directly into the bloodstream; products that lack sterility assurance pose a risk of serious bacterial infection.
The recalled products have a beyond-use date of December 2022 and were distributed to patients nationwide for use with or without a Curlin pump. Patients who received these TPN solutions should immediately contact their healthcare provider or Sentara Infusion Services to confirm whether their products are affected and determine the appropriate course of action.
If you have questions about whether a specific TPN product is part of this recall, contact Sentara Infusion Services or consult your healthcare provider. Do not use recalled TPN products.
The recalled product
- Product
- TPN (a) 100GM/AA, 285GM/DEX, (b)55GM/LIP 2300ML, (c)55GM/AA 285GM/DEX 50GM/LIP1800ML, (d)TPN AA:100GM DEX:250GM LIP:50GM 2400ML, (e) 55GM DEX:285GM 1800ML, Rx Only, use with Curlin pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeak
- Manufacturer
- Sentara Infusion Services
- Category
- Drug — Parenteral Nutrition
- Affected units
- 26
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Beyond Use Date: December 24-3
- 2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 53 recalled by Sentara Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 53 products in this recall →Related recalls
Same manufacturer · Sentara Infusion Services
See all →- HighEthanol 70% Syringes Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighDaptomycin Antibiotic Injectable Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighFluconazole 200mg injection recalled due to sterility concerns
FDA (Drugs) · 2023-02-22
- HighMeropenem Injectable Antibiotic Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighCefoxitin injectable bags recalled nationwide for sterility assurance failure
FDA (Drugs) · 2023-02-22
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15